40 and 80 mg strengths.

Cobalt Pharmaceuticals receives Notice of Compliance from Wellness Canada to advertise Atorvastatin Calcium Tablets Watson Pharmaceuticals, Inc. today announced that its subsidiary Cobalt Pharmaceuticals has received a Notice of Compliance from Health Canada to market Atorvastatin Calcium Tablets in the 10, 20, 40 and 80 mg strengths. We are very pleased our Cobalt company will become adding this important therapy to its growing portfolio of products, said Paul Bisaro, CEO and President of Watson Pharmaceuticals, Inc. .‘The goal was simple: To encourage our workers to be more physically active and make health and wellness a part of their lifestyle,’ explains Citizens Lender CEO and President Cathy Nash. ‘And today we know it was a big success.’ Altogether, a lot more than 1,300 employees voluntarily participated in acquiring positive actions toward healthier lifestyles. For instance, they climbed stairs, took lunchtime walks, worked their abdominals, lifted weights, plunged into backyard work, exercised at fitness centers, and signed up for sports teams.